Samcheondang Pharm closed higher, showing a relatively strong trend on the alternative trading system (NXT) compared to the Korea Exchange (KRX). In the market, there is an analysis that while price competition intensifies in a multi-market system, the superior matching intensity and price trends on NXT led to an inflow of short-term liquidity and an improvement in investor sentiment.

Based on the KRX market on the 11th, Samcheondang Pharm finished trading at 263,000 won, up 4,500 won (1.74%) from the previous trading day (258,500 won). The intraday high also recorded 263,000 won. On this day, the opening price was 250,500 won, the low was 237,500 won, and the trading volume was tallied at 308,243 shares. The current market capitalization is 6.1693 trillion won.

Volatility in the global market also affected the momentum of pharmaceutical stocks. Recently, military tensions between the United States and Iran have continued, expanding volatility in the global financial market. Generally, when geopolitical risks are highlighted, funds tend to move to defensive sectors such as pharmaceuticals and biotechnology rather than economically sensitive stocks.

The market is closely watching not only the development of the Middle East situation but also the individual companies' earnings and pipeline progress as variables that will determine the future stock price trends.

[This article was written with the assistance of AI. This article is intended to provide information for reference in making investment decisions and does not recommend the purchase or sale of specific stocks. Any losses resulting from stock investments are borne by the investor, and investment decisions must be made under sufficient review and responsibility.]